Home
Context: DPCO 2013
The Indian Pharmaceutical Market
History of Price Regulation in India
Details of DPCO 2013
Impact of DPCO on Different Stakeholders
Prior Research Results on DPCO 2013
Details of Regulations Post DPCO 2013
Data
Terminology Used
Data Preparation and Constructed Variables
Constructed Variable: Price Reduction of Regulated SKUs
Constructed Variable: Detailing Index of Molecules
Price Changes of Unregulated SKUs
Empirical Results
Summary: Pre and Post Regulation Metrics
Difference-in-Difference Results
Generalized Synthetic Control Method Results
Triangulation Results
Summary of Results
SKU Wise Results
Heterogeneity Analysis
Mechanism
Lower Detailing of Regulated Drugs
Decline in Prescriptions by NonMBBS Physicians
Survey Evidence on Detailing – Prescription Correlations
Alternative Explanations
Conclusions
Home
Context: DPCO 2013
The Indian Pharmaceutical Market
History of Price Regulation in India
Details of DPCO 2013
Impact of DPCO on Different Stakeholders
Prior Research Results on DPCO 2013
Details of Regulations Post DPCO 2013
Data
Terminology Used
Data Preparation and Constructed Variables
Constructed Variable: Price Reduction of Regulated SKUs
Constructed Variable: Detailing Index of Molecules
Price Changes of Unregulated SKUs
Empirical Results
Summary: Pre and Post Regulation Metrics
Difference-in-Difference Results
Generalized Synthetic Control Method Results
Triangulation Results
Summary of Results
SKU Wise Results
Heterogeneity Analysis
Mechanism
Lower Detailing of Regulated Drugs
Decline in Prescriptions by NonMBBS Physicians
Survey Evidence on Detailing – Prescription Correlations
Alternative Explanations
Conclusions
glossary